U.S. markets closed

Bayer Aktiengesellschaft (BAYN.SW)

Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
67.990.00 (0.00%)
At close: 4:53PM CEST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close67.99
Open67.64
Bid50.00 x 0
Ask130.00 x 0
Day's Range67.61 - 68.18
52 Week Range60.00 - 104.00
Volume790
Avg. Volume0
Market Cap38.73B
Beta (5Y Monthly)1.26
PE Ratio (TTM)9.22
EPS (TTM)7.38
Earnings DateN/A
Forward Dividend & Yield2.95 (2.84%)
Ex-Dividend DateApr 29, 2020
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Moody's

      Regeneron Pharmaceuticals, Inc. -- Moody's assigns Baa3 issuer rating to Regeneron

      NOTE: On August 07, 2020, the press release was corrected as follows: In the debt list, the description under “Ratings assigned” was changed to “Issuer rating, Baa3.” Revised release follows. New York, August 05, 2020 -- Moody's Investors Service ("Moody's") assigned a Baa3 issuer rating to Regeneron Pharmaceuticals, Inc. ("Regeneron"). "Regeneron's investment grade rating reflects growing global scale, strong scientific expertise, and an extremely conservative balance sheet, with very low financial leverage helping to mitigate business risks," stated Michael Levesque, Senior Vice President.

    • Moody's

      Root Bidco S.a.r.l. -- Moody's assigns B2 to Root Bidco, TLB, RCF; negative outlook

      Moody's Investors Service, ("Moody's") today assigned a B2 corporate family rating (CFR) and a B2-PD probability of default rating to Root Bidco S.a.r.l. Moody's expects to withdraw all ratings for EUROPEAN CROPS PRODUCTS 2 S.A.R.L. once the transaction closes in late 2020. The company since 2016 has grown from a revenue base of E225 million organically and through acquisitions.

    • Moody's

      Regeneron Pharmaceuticals, Inc. -- Moody's rates Regeneron's sr. notes Baa3; stable outlook

      Moody's Investors Service ("Moody's") assigned a Baa3 rating to the new senior unsecured notes of Regeneron Pharmaceuticals, Inc. ("Regeneron"). "Regeneron's investment grade rating reflects growing global scale, strong scientific expertise, and an extremely conservative balance sheet, with very low financial leverage helping to mitigate business risks," stated Michael Levesque, Senior Vice President.